A British baby’s death this year after getting Novartis’s gene therapy Zolgensma was not caused by a toxic drug reaction, the Swiss drugmaker said, allaying concerns over the $2.1 million-per-patient treatment’s risks.
An independent expert panel to the U.S. Food and Drug Administration on Wednesday recommended approval of GlaxoSmithKline Plc’s over-the-counter nicotine oral spray that aims to help smokers quit their addiction.
For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking laws and warehouse capacity as they seek to guarantee the supply of life-saving drugs through a chaotic Brexit.
With Britain sourcing the vast majority of the insulin needed by its 1 million diabetics from overseas, its biggest providers have had to restructure their supply chains in case a chaotic Brexit disrupts the normal arteries of trade.
Chris is co-founder and director of Research Engine Limited. The Research Engine platform provides ‘ready to use’ market research products delivering professional insights in hours or days rather than weeks & months - at price levels making research more affordable. Before founding the new platform last year Chris served clients for 15 years in marketing research and consultancy. Before that he spent 22 years client-side in a range of marketing and product development roles in major life sciences manufacturers – including UK, European, Asia Pacific & Global roles. With his strong marketing background Chris is particularly focused on helping clients make better strategic decisions thanks to great insights.